Back to companies

Bigfoot Biomedical Inc: Overview

Select Item

Bigfoot Biomedical Inc (Bigfoot Biomedical) is a medical device company that develops technologies to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. It leverages data, connectivity, automation, and machine learning to automatically and continuously optimize insulin delivery for people with insulin-requiring diabetes and maximize the leverage of health care providers. Bigfoot Biomedical provides automated infusion pump and connected insulin pen options for consumers to meet the needs of a diverse population with insulin-requiring diabetes.

 Gain a 360-degree view of Bigfoot Biomedical Inc and make more informed decisions for your business Gain a 360-degree view of Bigfoot Biomedical Inc and make more informed decisions for your business Contact Us
Headquarters United States of America
Address 1561 Buckeye Drive, Milpitas, California, 95035
Website www.bigfootbiomedical.com
No of Employees 50
Industry Medical Equipment
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Bigfoot Biomedical Inc premium industry data and analytics

3

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

2

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In September, the company signed an agreement to be acquired by Abbott.
2023 Acquisitions/Mergers/Takeovers In March, the company acquired a reinforcement learning algorithm for insulin titration from McGill University.
2023 Asset Disposal In February, the company sold assets related to its pump-based automated insulin delivery (AID) technologies for US$25 million to Insulet Corporation.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader
Executives
Name Position Board Since Age
Jeffrey Brewer President; Chief Executive Officer Senior Management - -
Brett Hale Chief Financial Officer Senior Management - -
Jon Brilliant Chief Strategy Officer Senior Management - -
Ian Hanson Chief Technology Officer Senior Management 2018 -
Mika Miettinen Vice President - Research & Development Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Bigfoot Biomedical Inc key executives to enhance your sales strategy Gain insight into Bigfoot Biomedical Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward